Fulfilling unmet needs
CognivAiD introduces a new approach to the treatment of dementia with its innovative therapeutic strategy.
![Cognivaid-stacked-boxes-left (1) CognivAiD contains Croci Stigma, Ginkgo Folium and Ginseng Radix et Rhizoma](https://cognivaid.com/wp-content/uploads/2023/05/Cognivaid-stacked-boxes-left-1-e1683611078229.png)
A novel approach
Neurological conditions involve multiple complex and interconnected biological processes. CognivAiD employs a multi-modal approach that simultaneously targets key disease-causing mechanisms of vascular dementia.
Evidence-Based Development
- EEstablished pharmacological properties and mechanisms of action
- EScientifically researched
- EPost-marketing surveillance
![cognivaid-graphic5-min Microscope used in scientific research](https://cognivaid.com/wp-content/uploads/2022/07/cognivaid-graphic5-min.png)
![CognivAiD logo-min](https://cognivaid.com/wp-content/uploads/2022/09/CognivAiD-logo-min.png)
represents a new generation of evidence-based natural products and a long-awaited addition to the treatment armamentarium of dementia.